2020-16401. Bulk Manufacturer of Controlled Substances Application: Euticals Inc.  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 28, 2020.

    Start Printed Page 45700

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on June 5, 2020, Euticals Inc., 2460 W Bennett Street, Springfield, Missouri 65807-1229, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Amphetamine1100II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Phenylacetone8501II
    Methadone9250II
    Methadone intermediate9254II
    Oripavine9330II
    Tapentadol9780II

    The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. No other activities for these drug codes are authorized for this registration.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-16401 Filed 7-28-20; 8:45 am]

    BILLING CODE P

Document Information

Published:
07/29/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-16401
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 28, 2020.
Pages:
45699-45700 (2 pages)
Docket Numbers:
Docket No. DEA-684
PDF File:
2020-16401.pdf